182 related articles for article (PubMed ID: 33070355)
1. International travel to obtain medical treatment for primary retinoblastoma: A global cohort study.
Bowman RJC; Foster A; Stacey A; Keren-Froim N; Bascaran C; Kivelä TT; Munier F; Fabian ID
Int J Cancer; 2021 Apr; 148(8):1858-1866. PubMed ID: 33070355
[TBL] [Abstract][Full Text] [Related]
2. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
3. Global retinoblastoma studies: A review.
Vempuluru VS; Maniar A; Kaliki S
Clin Exp Ophthalmol; 2024 Apr; 52(3):334-354. PubMed ID: 38263682
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma in a pediatric oncology reference center in Southern Brazil.
Selistre SGA; Maestri MK; Santos-Silva P; Schüler-Faccini L; Guimarães LSP; Giacomazzi J; Evangelista Júnior MC; Ashton-Prolla P
BMC Pediatr; 2016 Apr; 16():48. PubMed ID: 27038613
[TBL] [Abstract][Full Text] [Related]
5. Examinations under anaesthesia as a measure of disease burden in unilateral retinoblastoma: the London experience.
Fabian ID; Shah V; Kapelushnik N; Naeem Z; Onadim Z; Price E; Chowdhury T; Duncan C; Stansfield D; Sagoo M; Reddy MA
Br J Ophthalmol; 2020 Jan; 104(1):17-22. PubMed ID: 30862620
[TBL] [Abstract][Full Text] [Related]
6. A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources.
Waddell K; Matua M; Bidwell C; Atwine R; Onyango J; Picton SV; Simmons I; Stahlschmidt J; Johnston WT; Newton R
Cancer Epidemiol; 2021 Apr; 71(Pt B):101777. PubMed ID: 32660850
[TBL] [Abstract][Full Text] [Related]
7. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.
Global Retinoblastoma Study Group
Lancet Glob Health; 2022 Aug; 10(8):e1128-e1140. PubMed ID: 35839812
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma.
Mehta M; Sethi S; Pushker N; Kashyap S; Sen S; Bajaj MS; Ghose S
Singapore Med J; 2012 Feb; 53(2):128-35; quiz 136. PubMed ID: 22337189
[TBL] [Abstract][Full Text] [Related]
9. Who wants to cross borders in the EU for healthcare? An analysis of the Eurobarometer data in 2007 and 2014.
Peralta-Santos A; Perelman J
Eur J Public Health; 2018 Oct; 28(5):879-884. PubMed ID: 29697799
[TBL] [Abstract][Full Text] [Related]
10. [Pay attention to the application of the international intraocular retinoblastoma classification and sequential multiple modality treatment].
Fan XQ
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):561-565. PubMed ID: 28851194
[TBL] [Abstract][Full Text] [Related]
11. Circumvention tourism.
Cohen G
Cornell Law Rev; 2012 Sep; 97(6):1309-98. PubMed ID: 23072007
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of retinoblastoma in the context of a low-resource country.
Ademola-Popoola DS; Opocher E; Reddy MA
Niger Postgrad Med J; 2019; 26(2):69-79. PubMed ID: 31187745
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome.
Al-Haddad C; Bashour Z; Farah L; Bayram L; Merabe Z; Ma'luf R; Alameddine R; Eid T; Geara F; Wilson M; Brennan R; Jeha S; Ghanem K; Yousef RA; Farah R; Noun P; Yassine N; Inati A; Muwakkit S; Abboud M; Tarek N; Hamideh D; Saab R
Pediatr Blood Cancer; 2019 Nov; 66(11):e27959. PubMed ID: 31423715
[TBL] [Abstract][Full Text] [Related]
14. Outcome of extraocular retinoblastoma in a resource limited center from low middle income country.
Pant G; Verma N; Kumar A; Pooniya V; Gupta SK
Pediatr Hematol Oncol; 2017 Nov; 34(8):419-424. PubMed ID: 29337595
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma diagnosis: a proposal based on the experience of Centro Infantil Boldrini, Brazil.
Palazzi MA; Stephan C; Brandalise SR; Aguiar Sdos S
Pediatr Hematol Oncol; 2013 Aug; 30(5):379-85. PubMed ID: 23484635
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
[TBL] [Abstract][Full Text] [Related]
17. [The first experience of using OCT in diagnosis of primary and residual retinoblastoma].
Neroev VV; Saakian SV; Miakoshina EB; Tatskov RA; Zaĭtseva OV; Riabina MV
Vestn Oftalmol; 2012; 128(2):8-12. PubMed ID: 22834231
[TBL] [Abstract][Full Text] [Related]
18. The development of young children with retinoblastoma.
Ross G; Lipper EG; Abramson D; Preiser L
Arch Pediatr Adolesc Med; 2001 Jan; 155(1):80-3. PubMed ID: 11177067
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and outcome of retinoblastoma based on age at presentation: a review of 1450 children.
Kaliki S; Maniar A; Patel A; Palkonda VAR; Mohamed A
Int Ophthalmol; 2020 Jan; 40(1):99-107. PubMed ID: 31444587
[TBL] [Abstract][Full Text] [Related]
20. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes).
Kaliki S; Patel A; Iram S; Ramappa G; Mohamed A; Palkonda VAR
Retina; 2019 Feb; 39(2):379-391. PubMed ID: 29210937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
